Erythromycin is given in intestinal hypomotility because :
**Core Concept**
Erythromycin is a macrolide antibiotic that also acts as a motilin receptor agonist. Motilin is a hormone that stimulates gastrointestinal motility by binding to motilin receptors in the gastrointestinal tract. By activating these receptors, erythromycin enhances gastrointestinal contractions and improves intestinal motility.
**Why the Correct Answer is Right**
Erythromycin's motilin agonist activity is responsible for its therapeutic effect in intestinal hypomotility. When administered, erythromycin binds to motilin receptors in the gastrointestinal tract, leading to an increase in the frequency and amplitude of gastrointestinal contractions. This enhanced motility helps to improve the movement of food through the digestive system, alleviating symptoms of intestinal hypomotility.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is likely incorrect because erythromycin's primary mechanism of action as an antibiotic is not relevant to its use in treating intestinal hypomotility.
* **Option B:** This option is incorrect because metoclopramide, a dopamine antagonist, is a different class of medication that also enhances gastrointestinal motility, but through a different mechanism.
* **Option C:** This option is likely incorrect because domperidone, a dopamine antagonist, is a different class of medication that also enhances gastrointestinal motility, but through a different mechanism.
**Clinical Pearl / High-Yield Fact**
Erythromycin's motilin agonist activity can lead to gastrointestinal side effects such as nausea, vomiting, and diarrhea, especially when used at high doses or for extended periods.
**Correct Answer: C. Erythromycin can be used to treat intestinal hypomotility due to its motilin agonist activity, which enhances gastrointestinal contractions and improves intestinal motility.**